Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'
Top Cited Papers
- 1 April 2004
- journal article
- review article
- Published by Springer Nature in Nature Reviews Microbiology
- Vol. 2 (4) , 289-300
- https://doi.org/10.1038/nrmicro862
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Optimal Sampling Schedule Design for Populations of PatientsAntimicrobial Agents and Chemotherapy, 2003
- Pharmacodynamics of the New Fluoroquinolone Gatifloxacin in Murine Thigh and Lung Infection ModelsAntimicrobial Agents and Chemotherapy, 2002
- Rational Dose Selection for a Nonnucleoside Reverse Transcriptase Inhibitor through Use of Population Pharmacokinetic Modeling and Monte Carlo SimulationAntimicrobial Agents and Chemotherapy, 2002
- Pharmacodynamics of Fluoroquinolones against Streptococcus pneumoniae in Patients with Community-Acquired Respiratory Tract InfectionsAntimicrobial Agents and Chemotherapy, 2001
- Correlation of Antimicrobial Pharmacokinetic Parameters with Therapeutic Efficacy in an Animal ModelThe Journal of Infectious Diseases, 1988
- Nonparametric maximum likelihood estimation for population pharmacokinetics, with application to cyclosporineJournal of Pharmacokinetics and Biopharmaceutics, 1988
- Inhibition of cell wall synthesis and acylation of the penicillin binding proteins during prolonged exposure of growing Streptococcus pneumoniae to benzylpenicillinEuropean Journal of Biochemistry, 1985
- Effect of protein binding on antibiotic activity in vivoJournal of Antimicrobial Chemotherapy, 1983
- Optimal sampling times for pharmacokinetic experimentsJournal of Pharmacokinetics and Biopharmaceutics, 1981
- Estimation of population characteristics of pharmacokinetic parameters from routine clinical dataJournal of Pharmacokinetics and Biopharmaceutics, 1977